Market Research Logo

The Global Market for Biomarkers, 2015-2020 (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)

The Global Market for Biomarkers (Cancer Biomarkers, Cardiovascular Disease Biomarkers, Immunological Disease Biomarkers, Infectious Disease Biomarkers, Neurological Disease Biomarkers, Novel Biomarkers for Other Diseases)

The Global Market for Biomarkers analyzes the current and future markets for biomarkers. The report provides a market analysis for six broad areas of medical biomarkers:

  • The Market for Cancer Biomarkers
  • The Market for Cardiovascular Disease Biomarkers
  • The Market for Immunological Disease Biomarkers
  • The Market for Infectious Disease Biomarkers
  • The Market for Neurological Disease Biomarkers
  • The Market for Novel Biomarkers for Other Diseases
For each area, selected biomarkers and companies developing/marketing these biomarkers are provided.

Market analyses in this report cover world markets for biomarker diagnostic markets, including the following segmentation:
  • Worldwide Diagnostic Biomarker Market by Disease Indication – 2015 and 2020
  • Worldwide Cancer Biomarkers Diagnostic Market – 2015 and 2020
  • Worldwide Cardiovascular Disease Biomarkers Diagnostic Market – 2015 and 2020
  • Worldwide Autoimmune Disease and Allergy Biomarkers Diagnostic Market – 2015 and 2020
  • Worldwide Infectious Disease Biomarkers Diagnostic Market – 2015 and 2020
  • Worldwide Diagnostic Market for Selected Other Biomarkers – 2015 and 2020
  • Worldwide Biomarker Market - Diagnostic versus Research Applications – 2015 and 2020
  • Worldwide Biomarker Market by Geography – 2015 and 2020 (North America, European Union, Japan, ROW, Total)
The world markets for biomarkers and biomarker tests are provided in U.S. dollars for 2015 and 2020. The worldwide market for biomarkers by disease indication is provided, including the market for tests for biomarkers (diagnostics products) sold to clinical laboratories, and also products sold to researchers.

Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. Biomarkers also have important roles in drug discovery and development.

The biomarker market is large, reflecting the large market for diagnostic tests based on these biomarkers, and also the ongoing efforts to discovery, validate, and commercialize new biomarkers. Growth in this market is fueled by factors that are fostering the growth of both the research and the diagnostics market. Market drivers and challenges are discussed in the report.

The large and growing biomarker market has attracted a lot of attention, and companies entering the market. Thus this has become a highly competitive market. The report profiles companies involved in the biomarkers market.

The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.


  • Executive Summary
    • OVERVIEW
    • SCOPE AND METHODOLOGY
    • MARKET OVERVIEW
      • Table Worldwide Biomarker Market, 2015 and 2020 ($ millions)
    • PROGNOSIS FOR GROWTH
  • Introduction
    • WHAT ARE BIOMARKERS?
    • POINT-OF-VIEW
  • Selected Technologies Used to Identify and Analyze Biomarkers
    • IMMUNOASSAYS
      • Overview - Immunoassays
      • Immunoassay Instrument Platforms
        • Table Selected Companies Using Immunoassays for Detection and Analysis of Biomarkers
    • IMMUNOHISTOCHEMISTRY (IHC)
      • Table Selected Companies with Immunohistochemistry Tests on the Market or In Development for Detection of Biomarkers
    • FLOW CYTOMETRY
    • IN SITU HYBRIDIZATION
      • Table Selected Companies Using In Situ Hybridization for Detection and Analysis of Biomarkers
    • NUCLEIC ACID AMPLIFICATION TECHNOLOGIES
      • Table Selected Companies Using PCR or Other Nucleic Acid Amplification Based Technologies for Biomarker Assays
    • ANALYSIS OF GENE EXPRESSION PATTERNS (GENE SIGNATURES)
      • Table Selected Examples of Companies Analyzing Gene Expression Patterns ("Gene Signatures")
    • MICROARRAYS
      • Table Selected Companies Using Microarrays to Detect and Analyze Biomarkers
      • Protein Microarrays
      • DNA Microarrays
      • Chromosomal Microarrays
      • Tissue Microarrays
    • SEQUENCING TECHNOLOGIES
      • Table Selected Diagnostic Companies and Clinical Laboratories with Sequencing-Based Biomarker Assays
      • Sanger Sequencing
      • Early Next Generation Sequencing Technologies
      • Sequencing by Synthesis (SBS)
      • Supported Oligonucleotide Ligation and Detection (SOLiD)
      • Ion Torrent Sequencing
      • Newer Next Generation Sequencing Technologies
      • Sequencing Technologies Summary – Impact on Biomarkers
    • MASS SPECTROMETRY
      • Mass Spectrometry Technology
      • Research and Clinical Applications of Mass Spectrometry
        • Table Selected Companies Using Mass Spectrometry
    • NON-INVASIVE PRENATAL TESTING
    • LIQUID BIOPSIES - CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA (CELL FREE DNA)
    • DIGITAL PATHOLOGY AND IMAGE CYTOMETRY
    • INFORMATION TECHNOLOGY
  • Cancer Biomarkers
    • OVERVIEW
      • Table Estimated Global Incidence and Mortality due to Cancer, 2012 – By Regions of the World
      • Table Estimated Global Incidence and Mortality due to Cancer, 2012 – By Type of Cancer
      • Table Selected Widely Used Tumor Markers
    • CANCER BIOMARKERS
      • Assessing Risk of Cancer
        • Table Selected Biomarkers and Biomarker Panels to Assess Risk of Cancer, and Companies Developing/Marketing These Biomarkers
      • Cancer Screening
        • Table Selected Biomarkers and Biomarker Panels for Cancer Screening, and Companies Developing/Marketing These Biomarkers
      • Diagnosis and Monitoring of Cancer
        • Table Selected Biomarkers and Biomarker Panels for Diagnosis and/or Monitoring of Cancer, and Companies Developing/Marketing These Biomarkers
      • Predicting Prognosis
        • Table Selected Biomarkers and Biomarker Panels to Predict Prognosis of Cancer, and Companies Developing/Marketing These Biomarkers
      • Personalized Medicine/Precision Testing
        • Table Selected Biomarkers and Biomarker Panels to Predict Response to Therapy, and Companies Developing/Marketing These Biomarkers
        • Table Selected FDA Cleared/Approved Companion Diagnostic Tests, and Companies Developing/Marketing These Biomarkers
    • COMPETITION IN CANCER BIOMARKERS
      • Table Selected Companies Developing/Marketing Cancer Tests
  • Cardiovascular Disease Biomarkers
    • OVERVIEW
    • ACUTE MYOCARDIAL INFARCTION AND ACUTE CORONARY SYNDROME
    • HEART FAILURE
      • Table Selected Biomarkers and Biomarker Panels for Cardiovascular Disease, and Companies Developing/Marketing These Biomarkers
    • LIPID DISORDERS
      • Table Selected Lipid Biomarkers, and Companies Developing/Marketing These Biomarkers
  • Immunological Disease Biomarkers
    • AUTOIMMUNE DISEASE BIOMARKERS
    • INFLAMMATION/INFLAMMATORY DISEASE BIOMARKERS
    • SELECTED OTHER IMMUNE-RELATED DISORDERS
      • Table Selected Biomarkers for Immunological Disorders, and the Companies Developing/Marketing These Biomarkers
  • Infectious Disease Biomarkers
    • OVERVIEW
    • CURRENT INFECTIOUS DISEASE DIAGNOSTICS AND EMERGING THREATS
      • Table Selected Biomarkers for Infectious Diseases, and Companies Developing/Marketing These Biomarkers
    • ANTIBIOTIC RESISTANCE
      • Table Selected Biomarkers and Other Tests for Antibiotic Resistance, and Companies Developing/Marketing These Biomarkers
    • SEPSIS
      • Table Selected Biomarkers for Sepsis, and Companies Developing/Marketing These Biomarkers
  • Neurological Disease Biomarkers
    • OVERVIEW
    • ALZHEIMER'S DISEASE
    • EMERGING BIOMARKERS FOR NEUROLOGICAL DISORDERS
      • Table Selected Biomarkers and Biomarker Panels for Neurological Disorders, and Companies Developing/Marketing These Biomarkers
  • Novel Biomarkers for Other Diseases
    • OVERVIEW
    • COMPANIES DEVELOPING NOVEL BIOMARKERS
      • Table Selected Biomarkers and Biomarker Panels for Other Diseases, and Companies Developing/Marketing These Biomarkers
  • Deals
    • Table Selected Acquisitions of Biomarker Companies
  • Biomarkers – Market Drivers and Challenge
    • BIOMARKER MARKETS
    • MARKET DRIVERS FOR DIAGNOSTIC APPLICATIONS OF BIOMARKERS
    • ISSUES AND HURDLES FACED BY IN VITRODIAGNOSTIC COMPANIES
    • MARKET DRIVERS FOR RESEARCH APPLICATIONS OF BIOMARKERS
    • BIOMARKERS IN DRUG DEVELOPMENT
      • Table Biomarker Qualification Submissions – Food and Drug Administration
    • PHARMACOGENOMIC BIOMARKERS
      • Table Pharmacogenomic Biomarkers in Drug Labeling
    • ADVANCES IN TECHNOLOGY CHANGING THE FUTURE OF BIOMARKERS
    • BIOMARKER PANELS
    • WORKING TOGETHER TO DISCOVER AND VALIDATE NEW BIOMARKERS – ALLIANCES, CONSORTIUMS, AND OTHER GROUPS
    • VALIDATION OF BIOMARKERS
    • FUTURE PROSPECTS
  • Biomarker Market Analysis
    • DIAGNOSTIC BIOMARKER MARKET BY DISEASE INDICATION
      • Table Worldwide Diagnostic Biomarker Market by Disease Indication – 2015 and 2020(Cancer, Cardiovascular disease, Autoimmune disease and allergy, Infectious disease, Other disease applications, Total) ($ millions)
      • Cancer Biomarkers
        • Table Worldwide Cancer Biomarkers Diagnostic Market – 2015 and 2020 (IHC, ISH, PSA, CEA, CA 125, AFP, Other Immunoassays – Tumor Markers, Flow Cytometry, Fecal occult blood, Rapid Tests – PSA, NMP22, Rapid Tests – Other, Molecular Assays [EGFR, HER2, Others], Total) ($ millions)
      • Cardiovascular Disease Biomarkers
        • Table Worldwide Cardiovascular Disease Biomarkers Diagnostic Market – 2015 and 2020 (Acute Condition Cardiac Markers: CK-MB, troponin I, troponin T, myoglobin, brain natriuretic peptide [BNP]; Other cardiac markers: proBNP, hsCRP, homocysteine, others; Cholesterol/Lipids; Coagulation: PT/INR - lab, D-dimer, Molecular [Thrombophilia SNPs], POC; Total) ($ millions)
      • Autoimmune Disease and Allergy Biomarkers
        • Table Worldwide Autoimmune Disease and Allergy Biomarkers Diagnostic Market – 2015 and 2020 ($ millions)
      • Infectious Disease Biomarkers
        • Table Worldwide Infectious Disease Biomarkers Diagnostic Market – 2015 and 2020 (Laboratory immunoassays: Hepatitis, HIV, STDs, TORCH, Respiratory, Sepsis, Parasitology, Mycology, Others; Rapid immunoassays: Influenza, HIV, Malaria, Hepatitis, STDs, C. difficile, E. coli, Strep A, H. pylori, Others; Molecular assays: Healthcare-Acquired Infections [HAIs], HIV, Hepatitis, Chlamydia/Gonorrhea [CT/NG], HPV, Respiratory, Mycobacteria/TB, Other; Total) ($ millions)
      • Biomarkers for Other Diseases
        • Table Worldwide Diagnostic Market for Selected Other Biomarkers – 2015 and 2020(General Clinical Chemistry, Fertility/Pregnancy, Thyroid, Diabetes/HbA1c, Chromosome Analysis and Inherited Disease, Cystic Fibrosis, Other, Total) ($ millions)
    • BIOMARKER MARKET–RESEARCH VERSUS DIAGNOSTIC APPLICATIONS
      • Table Worldwide Biomarker Market - Diagnostic versus Research Applications – 2015 and 2020 ($ millions)
    • BIOMARKER MARKET–GEOGRAPHICAL DISTRIBUTION
      • Table Worldwide Biomarker Market by Geography – 2015 and 2020 (North America, European Union, Japan, ROW, Total) ($ millions)
  • Company Profiles: Biomarker Companies
    • 14M GENOMICS LTD.
    • 20/20 GENESYSTEMS, INC.
    • 23ANDME, INC.
    • A&G PHARMACEUTICAL, INC.
    • ABACUS DIAGNOSTICA OY
    • ABBOTT LABORATORIES
      • Recent Revenue History
      • Company Overview – Focusing on Biomarkers
    • ABCODIA LTD.
    • ACCELERATE DIAGNOSTICS, INC.
      • Recent Revenue History
      • Company Overview
    • ACOBIOM
    • ACT GENOMICS CO., LTD.
    • ACUMEN PHARMACEUTICALS, INC.
    • ADAPTIVE BIOTECHNOLOGIES CORPORATION
    • ADLYFE INC.
    • ADMERA HEALTH (A GENEWIZ COMPANY)
    • AESKU.DIAGNOSTICS
    • AFFYMETRIX, INC.
      • Recent Revenue History
      • Company Overview
    • AGENA BIOSCIENCE INC.
    • AGENDIA NV
    • AGILENT TECHNOLOGIES INC.
      • Recent Revenue History
      • Company Overview
    • ALERE INC.
      • Recent Revenue History
      • Company Overview
    • ALMAC GROUP LIMITED
    • ALPCO
    • AMARANTUS BIOSCIENCE HOLDINGS, INC.
    • AMBRY GENETICS CORP.
    • APERIOMICS, INC.
    • APOCELL, INC.
    • APPLIED PROTEOMICS, INC.
    • ASSOCIATES OF CAPE COD, INC. (ACC)
    • ASURAGEN, INC.
    • ASYMMETRXMEDICAL, INC.
    • ATHENA DIAGNOSTICS, INC. (AQUEST DIAGNOSTICS BUSINESS)
    • ATLAS GENETICS LTD
    • ATOSSA GENETICS INC.
      • Recent Revenue History
      • Company Overview
    • AUGUREX LIFE SCIENCES CORP.
    • AUGURIX SA/AUGURIX DIAGNOSTICS
    • AVANT DIAGNOSTICS, INC. (FORMERLY ARRAYIT DIAGNOSTICS INC.)
    • AXELA, INC.
    • AXIS-SHIELD DIAGNOSTICS, LTD. (AN ALERE COMPANY)
      • Recent Revenue History
      • Company Overview
    • AXO SCIENCE
    • BANYAN BIOMARKERS, INC.
    • BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION)
      • Recent Revenue History
      • Company Overview
    • BECTON, DICKINSON AND COMPANY (BD)
      • Recent Revenue History
      • Company Overview
    • BG MEDICINE, INC.
      • Recent Revenue History
      • Company Overview
    • THE BINDING SITE GROUP LTD.
      • Recent Revenue History
      • Company Overview
    • BIOCARTIS SA
      • Recent Revenue History
      • Company Overview
    • BIOCRATES LIFE SCIENCES AG
    • BIODESIX, INC.
    • BIOFIRE DIAGNOSTICS, LLC (ACQUIRED BY BIOMÉRIEUX)
      • Recent Revenue History and Other Financial Information
      • Company Overview
    • BIOHIT OYJ
      • Recent Revenue History
      • Company Overview
    • BIOINNOVATION SOLUTIONS SA
    • BIOMARKER STRATEGIES
    • BIOMEDOMICS, INC.
    • BIOMÉRIEUX SA
      • Recent Revenue History
      • Company Overview
    • BIOMOSAICS INC.
    • BIOPORTO DIAGNOSTICS A/S
      • Recent Revenue History
      • Company Overview
    • BIO-RAD LABORATORIES, INC.
      • Recent Revenue History
      • Company Overview
    • BIOSYSTEMS INTERNATIONAL
    • BIOTHERANOSTICS, INC. (A BIOMÉRIEUX COMPANY)
    • BIOTYPE DIAGNOSTIC GMBH
    • BIOUNIVERSA S.R.L.
    • CANCER GENETICS, INC.
      • Recent Revenue History
      • Company Overview
    • CAPRION, INC.
    • CARDIODX, INC.
    • CARDIOGENICS HOLDINGS INC.
    • CAREDX, INC.
      • Recent Revenue History
      • Company Overview
    • CARIS LIFE SCIENCES
    • CASTLE BIOSCIENCES, INC.
    • CD DIAGNOSTICS, INC.
    • CELLMID LTD.
    • CENTOGENE AG
    • CEPHEID
      • Recent Revenue History
      • Company Overview
    • CHRONIX BIOMEDICAL, INC.
    • CLARIENT DIAGNOSTIC SERVICES, INC. (AGEHEALTHCARE COMPANY) (BEING ACQUIRED BY NEOGENOMICS, INC.)
      • Recent Revenue History
      • Company Overview
    • COURTAGEN LIFE SCIENCES, INC.
    • CRESCENDO BIOSCIENCE (SUBSIDIARY OF MYRIAD GENETICS)
    • CRITICAL DIAGNOSTICS
    • CURETIS AG
    • CYNVENIO BIOSYSTEMS, INC.
    • DAKO A/S (AN AGILENT COMPANY)
      • Recent Revenue History
      • Company Overview
    • DANAHER CORPORATION
      • Recent Revenue History
      • Company Overview
    • DECODE GENETICS
    • DIADEXUS, INC.
      • Recent Revenue History
      • Company Overview
    • DIAGENIC ASA
    • DIAGENICS SE
      • Diagenics International Corporation
    • DIAXONHIT
      • Recent Revenue History
      • Company Overview
    • DNA ELECTRONICS LTD. (DNAE)
    • ENTROGEN, INC.
    • EPIC SCIENCES, INC.
    • EPIGENOMICS AG
      • Recent Revenue History
      • Company Overview
    • EPINEX DIAGNOSTICS, INC.
    • EUTROPICS PHARMACEUTICALS
    • EXACT SCIENCES CORPORATION
      • Recent Revenue History
      • Company Overview
    • EXIQON A/S
      • Recent Revenue History
      • Company Overview
    • FOUNDATION MEDICINE, INC.
      • Recent Revenue History
      • Company Overview
    • FUJIREBIO INC.
    • FUJIREBIO DIAGNOSITICS, INC.
      • Recent Revenue History
      • Company Overview
    • GAMMA THERAPEUTICS, INC.
    • GENALYTE, INC.
    • GENECENTRIC DIAGNOSTICS, INC.
    • GENECTION, INC. (AN INVIVOSCRIBE COMPANY)
    • GENENEWS LIMITED AND INNOVATIVE DIAGNOSTIC LABORATORY
    • GENOMEDX BIOSCIENCES
    • GENOMEON LLC
    • GENOMIC HEALTH, INC.
      • Recent Revenue History
      • Company Overview
    • GENOMIC VISION
      • Recent Revenue History
      • Company Overview
    • GENOPTIX (A NOVARTIS COMPANY)
    • GUARDANT HEALTH, INC.
    • HALIODX
    • HELOMICS CORPORATION
    • HOLOGIC, INC.
      • Recent Revenue History
      • Company Overview
    • ILLUMINA, INC.
      • Recent Revenue History
      • Company Overview
    • IMMUNEXPRESS
    • INTEGRATED DIAGNOSTICS, INC.
    • INTRINSIC LIFESCIENCES
    • MYRIAD GENETICS, INC.
      • Recent Revenue History
      • Company Overview
    • NANOSTRING TECHNOLOGIES, INC.
      • Recent Revenue History
      • Company Overview
    • NEOGENOMICS, INC./NEOGENOMICS LABORATORIES
      • Recent Revenue History
      • Company Overview
    • ONCOLAB, INC.
    • ONCOSPIRE GENOMICS
    • OPKO HEALTH, INC./OPKO DIAGNOSTICS
      • Recent Revenue History
      • Company Overview
    • ORGENTEC DIAGNOSTIKA GMBH
    • ORION GENOMICS
    • ORTHO-CLINICAL DIAGNOSTICS
      • Recent Revenue History
      • Company Overview
    • OXFORD GENE TECHNOLOGY
    • PROTEOME SCIENCES PLC
      • Recent Revenue History
      • Company Overview
    • PSYNOVA NEUROTECH LTD.
    • QIAGEN N.V.
      • Recent Revenue History
      • Company Overview
    • QUANTERIX CORPORATION
    • RANDOX LABORATORIES LTD
    • RAPID PATHOGEN SCREENING, INC.
    • RELIA DIAGNOSTICS, INC.
    • RENESE UG
    • ROCHE
      • Recent Revenue History
      • Company Overview
    • SIEMENS HEALTHCARE DIAGNOSTICS
      • Recent Revenue History
      • Company Overview
    • SYSMEX CORPORATION
      • Recent Revenue History
      • Company Overview
    • THERMO FISHER SCIENTIFIC, INC.
      • Recent Revenue History
      • Company Overview
    • TOSOH CORPORATION
      • Recent Revenue History
      • Company Overview
    • VENTANA MEDICAL SYSTEMS, INC. (MEMBER OF THE ROCHE GROUP)
    • WAKO PURE CHEMICAL INDUSTRIES, LTD.,
    • XRGENOMICS LTD
    • ZEUS SCIENTIFIC, INC.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report